Commit To Purchase Apellis Pharmaceuticals At $12.50, Earn 21.6% Annualized Using Options
December 28, 2018 at 11:34 AM EST
Investors eyeing a purchase of Apellis Pharmaceuticals Inc (APLS) stock, but tentative about paying the going market price of $13.22/share, might benefit from considering selling puts among the alternative strategies at their disposal. One interesting put contract in particular, is the July 2019 put at the $12.50 strike, which has a bid at the time of this writing of $1.50..